BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
An Extended period of Voyaging Carefully: the World with Reason - 2Mobility exercises are an important part of fitness as we age. Here are some tips
- 3French Senate debates social media ban for under-15s
- 4Figure out How to Forestall Tooth Staining
- 5Japanese H3 rocket fails during launch of navigation satellite (video)
- Hezbollah uses ambulances, paramedic uniforms, as disguise for terrorist activity, IDF says
- NASA's moon mission has begun — here's what's ahead for the Artemis II astronauts
- 'Tangled' live-action movie casts Teagan Croft and Milo Manheim as Rapunzel and Flynn
- Scientist turns people’s mental images into text using ‘mind-captioning’ technology
- A Texas GOP congressman is retiring. Trump just endorsed his identical twin to replace him.
- What were the little white pills found in Tiger Woods's pocket at the scene of his crash? What to know about hydrocodone.
- Eating Brie, Gouda, cheddar may lower dementia risk, new study says
- Sound Propensities: 20 Methods for helping Your Insusceptible Framework
- Father and son spending Christmas together after health scares
